Campaign for RU486 &
Contraceptive Research |
|
Feminist Majority Report Articles on Mifepristone (RU
486)
FDA Considers Restrictions
on Mifepristone
Summer 2000 article on possible restrictions on mifepristone that
would grossly restrict access. This issue is in pdf format.
House Again Threatens RU
486 Approval
Summer 1999 article on the Coburn amendment to the Agricultural
Appropriations Bill. This issue is in pdf format.
Congressional Threat
to RU486 Stopped
Fall 1998 article on the defeat of the Coburn amendment that would
have halted mifepristone research.
Clinics Offer Abortion Pill
Spring 1998 report on federally approved mifepristone trials conducted
in the U.S.
Women Worldwide Closer
to RU 486 Access: Anti-RU 486 Boycott Backfires
Summer 1997 article on the transfer of RU 486 U.S. patent rights
to the Population Council.
Women in Developing Countries
Prefer Medical Abortion
Spring 1997 article based on Population Council study of women in
China, Cuba and India.
FDA Panel Finds Mifepristone
Safe, and Effective; Final Decision on "French Abortion Pill" to
Be Made By Mid- September
Summer 1996 article reporting on the FDA's findings that mifepristone
is both safe and effective.
RU 486 FDA Application Completed
Milestone Makes Approval in 1996 Likely
Spring 1996 article discusses the FDA's movement towards the approval
of Mifepristone.
Methotrexate May Offer
New Abortion Method
Fall 1995 article discusses the effectiveness of methotrexate, and
the drugs support by many medical practitioners.
RU 486 Wins Global Praise
From Women NGO Forum Panel Assesses Worldwide Use
Fall 1995 article discusses a Feminist Majority Foundation panel
on mifepristone at the U.N. Fourth World Conference on Women NGO
Forum in China.
Repro
Rights Home |
RU 486 & Contraceptive Research | National
Clinic Access Project | Rock
for Choice
Choices Campus Community | Abortion
Rights | Birth Control | Other Repro Health |
Global Repro Rights
|